Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advised Strax on an automatic redemption procedure
Mandate

Vinge advised Strax on an automatic redemption procedure

January 30, 2019 Capital Markets and Public M&A

Vinge has advised Strax AB in connection with an automatic redemption procedure according to which each outstanding share in Strax has been split into two shares, of which one share (called redemption share) has been redeemed for a proceed of SEK 1.10.

In aggregate, 120,592,332 shares were redeemed at an amount corresponding to approximately SEK 133 million. The redemption procedure was approved by the extraordinary general meeting on 28 December 2018 and the proceeds in the redemption procedure was paid on 30 January 2019.

Vinge’s team consisted mainly of Jesper Schönbeck, Rikard Lindahl, Malte Hedlund, Anna-Karin Alin and Julia Hirschberg. Maria Schultzberg and Henrik Wastenson advised on tax issues.
 

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026